Cargando…

Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors

Red blood cell (RBC) transfusions have been shown to exert immunosuppressive effects in different diseases. In consequence, RBC transfusions might also negatively influence the response to immunotherapeutic treatment approaches. To address how RBC transfusions impact response rates of antitumor immu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mispelbaum, Rebekka, Hattenhauer, Sandra Tessa, Brossart, Peter, Heine, Annkristin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492841/ https://www.ncbi.nlm.nih.gov/pubmed/36159812 http://dx.doi.org/10.3389/fimmu.2022.976011

Ejemplares similares

Baseline immune signature score of Tregs × HLA-DR(+)CD4(+) T cells × PD1(+)CD8(+) T cells predicts outcome to immunotherapy in cancer patients
por: Mispelbaum, Rebekka, et al.
Publicado: (2022)

Clinical and immunological effects of mRNA vaccines in malignant diseases
por: Heine, Annkristin, et al.
Publicado: (2021)

Spoilt for choice: different immunosuppressive potential of anaplastic lymphoma kinase inhibitors for non small cell lung cancer
por: Heine, Annkristin, et al.
Publicado: (2023)

Implementing combinatorial immunotherapeutic regimens against cancer: The concept of immunological conditioning
por: Wolf, Dominik, et al.
Publicado: (2014)

Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah’s Witness patient
por: Schlaweck, Sebastian, et al.
Publicado: (2021)

Two cases of EBV infection preceding lymphoma
por: Saal, Jonas, et al.
Publicado: (2022)

Initial investigation on the feasibility of porcine red blood cells from genetically modified pigs as an alternative to human red blood cells for transfusion
por: Park, Sangkeun, et al.
Publicado: (2023)

Tumor rejection in Cblb(−/−) mice depends on IL-9 and Th9 cells
por: Schanz, Oliver, et al.
Publicado: (2021)

ATG-Fresenius increases the risk of red blood cell transfusion after kidney transplantation
por: Sebti, Maria, et al.
Publicado: (2022)

RNA Vaccines in Cancer Treatment
por: Bringmann, Anita, et al.
Publicado: (2010)

Dexamethasone induced inhibition of Dectin-1 activation of antigen presenting cells is mediated via STAT-3 and NF-κB signaling pathways
por: Kotthoff, Philipp, et al.
Publicado: (2017)

G-quadruplexes: a promising target for cancer therapy
por: Kosiol, Nils, et al.
Publicado: (2021)

Elotuzumab spares dendritic cell integrity and functionality
por: Schlaweck, Sebastian, et al.
Publicado: (2021)

Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
por: Sloas, Christopher, et al.
Publicado: (2021)

Manipulating T-cell metabolism to enhance immunotherapy in solid tumor
por: Chen, Chen, et al.
Publicado: (2022)

BG-flow, a new flow cytometry tool for G-quadruplex quantification in fixed cells
por: De Magis, Alessio, et al.
Publicado: (2021)

The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells
por: Braun, Christiane, et al.
Publicado: (2021)

Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors
por: Kosti, Paris, et al.
Publicado: (2018)

Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors
por: Dolcetti, Riccardo, et al.
Publicado: (2020)

Obstacles and Coping Strategies of CAR-T Cell Immunotherapy in Solid Tumors
por: Miao, Lele, et al.
Publicado: (2021)

Revolution of CAR Engineering For Next-Generation Immunotherapy In Solid Tumors
por: Yu, Tao, et al.
Publicado: (2022)

Red blood cell transfusion in the resuscitation of septic patients with hematological malignancies
por: Mirouse, Adrien, et al.
Publicado: (2017)

The State of Cellular Adoptive Immunotherapy for Neuroblastoma and Other Pediatric Solid Tumors
por: Le, Thanh-Phuong, et al.
Publicado: (2017)

T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies
por: Janelle, Valérie, et al.
Publicado: (2020)

Editorial: Versatile Roles for B Cells in Tumor Immunity
por: Brossart, Peter
Publicado: (2022)

Red Blood Cell Transfusion
por: West, F. Bernadette, et al.
Publicado: (2015)

Deciphering Tumor Niches: Lessons From Solid and Hematological Malignancies
por: Mancini, Stéphane J.C., et al.
Publicado: (2021)

Nanoparticle-based drug delivery systems to enhance cancer immunotherapy in solid tumors
por: Zhang, Jiaxin, et al.
Publicado: (2023)

Early Post-Transplant Red Blood Cell Transfusion Is Associated With an Increased Risk of Transplant Failure: A Nationwide French Study
por: Gaiffe, Emilie, et al.
Publicado: (2022)

Associations of HER2 Mutation With Immune-Related Features and Immunotherapy Outcomes in Solid Tumors
por: Wang, Deqiang, et al.
Publicado: (2022)

Self-delivery of TIGIT-blocking scFv enhances CAR-T immunotherapy in solid tumors
por: Yang, Fan, et al.
Publicado: (2023)

Editorial: Immunological characteristics of malignant tumors of the hepatobiliary system and identification of immunotherapy targets
por: Zhang, Qiyao, et al.
Publicado: (2023)

Red blood cell transfusion Results
por: Miadda, R, et al.
Publicado: (2013)

Anemia and transfusion of red blood cells
por: Cortés Buelvas, Armando
Publicado: (2013)

Transfusion with Preserved Red Blood Cells
Publicado: (1918)

Editorial: Targeting metabolism to activate T cells and enhance the efficacy of checkpoint blockade immunotherapy in solid tumors
por: Xia, Zhijia, et al.
Publicado: (2023)

Case Report: Cord blood-derived natural killer cells as new potential immunotherapy drug for solid tumor: a case study for endometrial cancer
por: Mu, Yongxu, et al.
Publicado: (2023)

Successful Treatment of Refractory Squamous Cell Cancer of the Head and Neck with Nivolumab and Ipilimumab
por: Schwab, Katjana S., et al.
Publicado: (2018)

Guidelines on transfusion of red blood cells: Prognosis of patients who decline blood transfusions
por: Langhi, Dante Mário, et al.
Publicado: (2018)

Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?
por: Roerden, Malte, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fdc61qlff24ao4v55eavp2dfch